About: Roadmap to resuming care for liver diseases after coronavirus disease‐2019

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Roadmap to resuming care for liver diseases after coronavirus disease‐2019 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Roadmap to resuming care for liver diseases after coronavirus disease‐2019
Creator	Bollipo, Steven Congly, Stephen Dhanasekaran, Renumathy Siau, Keith Ben-Yakov, Gil Goutham Kumar, ¶ Kapuria, Devika Lee, Hye-Won Lui, N Rabiee, Atoosa Rashid, Correspondence Rashid, † Turnes, Juan
source	Medline; PMC
abstract	The global pandemic of coronavirus disease‐2019 (COVID‐19) has led to significant disruptions in healthcare delivery. Patients with chronic liver diseases require a high level of care and are therefore particularly vulnerable to disruptions in medical services during COVID‐19. Recent data have also identified chronic liver disease as an independent risk factor for COVID‐19 related hospital mortality. In response to the pandemic, national and international societies have recommended interim changes to the management of patients with liver diseases. These modifications included the implementation of telehealth, postponement or cancelation of elective procedures, and other non‐urgent patient care‐related activities. There is concern that reduced access to diagnosis and treatment can also lead to increased morbidity in patients with liver diseases and we may witness a delayed surge of hospitalizations related to decompensated liver disease after the COVID‐19 pandemic has receded. Therefore, it is paramount that liver practices craft a comprehensive plan for safe resumption of clinical operations while minimizing the risk of exposure to patients and health‐care professionals. Here, we provide a broad roadmap for how to safely resume care for patients with chronic liver disease according to various phases of the pandemic with particular emphasis on outpatient care, liver transplantation, liver cancer care, and endoscopy.
has issue date	2020-07-22(xsd:dateTime)
bibo:doi	10.1111/jgh.15178
bibo:pmid	32656794
has license	no-cc
sha1sum (hex)	b0ff609cdfddbffeec9b7ef3e7ad937710fa4062
schema:url	https://doi.org/10.1111/jgh.15178
resource representing a document's title	Roadmap to resuming care for liver diseases after coronavirus disease‐2019
has PubMed Central identifier	PMC7404933
has PubMed identifier	32656794
schema:publication	J Gastroenterol Hepatol
resource representing a document's body	covid:b0ff609cdfddbffeec9b7ef3e7ad937710fa4062#body_text
is schema:about of	named entity 'liver disease' named entity 'patients' named entity 'minimizing' named entity 'lead' named entity 'data' named entity 'high level' named entity 'care' named entity 'global' named entity 'pandemic' named entity 'chronic liver disease' named entity 'activities' named entity 'postponement' named entity 'telehealth' named entity 'risk factor' named entity 'COVID-19' named entity 'global pandemic' named entity 'liver diseases' named entity 'chronic liver disease' named entity 'outpatient care' named entity 'coronavirus disease' named entity 'healthcare delivery' named entity 'liver' named entity 'chronic liver disease' named entity 'morbidity' named entity 'chronic liver' named entity 'healthcare delivery' named entity 'COVID-19' named entity 'cirrhosis' named entity 'HCC' named entity 'liver transplantation' named entity 'COVID-19 pandemic' named entity 'chronic liver' named entity 'British Society of Gastroenterology' named entity 'antibody testing' named entity 'Spain' named entity 'living donor' named entity 'varices' named entity 'COVID-19' named entity 'PCR' named entity 'elective procedures' named entity 'American Society of Transplantation' named entity 'elective surgical' named entity 'chronic liver disease' named entity 'computed tomography' named entity 'esophagogastroduodenoscopy' named entity 'global pandemic' named entity 'polymerase chain reaction' named entity 'public health' named entity 'symptom' named entity 'immunosuppression' named entity 'Transplant surgery' named entity 'infection prevention and control' named entity 'immunosuppression' named entity 'endoscopy' named entity 'PCR testing' named entity 'risk group' named entity 'pharmacists' named entity 'liver' named entity 'portal hypertension' named entity '28 days' named entity 'imaging services' named entity 'COVID' named entity 'HCC' named entity 'outpatient' named entity 'endoscopies' named entity 'Inpatient' named entity 'Radiology' named entity 'epidemiological' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software